---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-090365"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:34:16.430682+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# InMed to participate in Fierce Biotech webinar on Alzheimer's neuroinflammation on Nov 12, 2024

## Summary
- InMed (Nasdaq: INM) announced participation in Fierce Biotech webinar on November 12, 2024.
- SVP of Preclinical R&D Dr. Eric Hsu will join a panel on neuroinflammation in Alzheimer's disease.
- Webinar topics include latest Alzheimer's research, therapeutic pathways, and drugs in development.
- Panel includes experts from Eli Lilly, Johns Hopkins, Michigan State, and Barrow Neurological Institute.
- No financial results or material business changes were disclosed in this filing.

## SEC filing metadata
- accession: 0001213900-24-090365
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390024090365/0001213900-24-090365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390024090365/ea0218583-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-090365
- JSON: https://secwatch.observer/filing/0001213900-24-090365.json
- Plain text: https://secwatch.observer/filing/0001213900-24-090365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.